Premium
Echocardiographic contrast imaging of the human right heart: A multicenter study of the efficacy, safety, and reproducibility of intravenous SHU‐454
Author(s) -
Rovai Daniele,
Lombardi Massimo,
Cini Giuseppe,
Morales Maria Aurora,
Colonna Maria,
Bechelli Giorgio,
Marino Paolo,
Zanolla Luisa,
Prioli Maria Antonia,
Nicolosi Gian Luigi,
Pavan Daniela,
Zanuttini Domenico,
Iliceto Sabino,
Izzi Michele,
Rizzon Paolo,
L'Abbate Antonio
Publication year - 1991
Publication title -
journal of clinical ultrasound
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.272
H-Index - 61
eISSN - 1097-0096
pISSN - 0091-2751
DOI - 10.1002/jcu.1870190902
Subject(s) - medicine , reproducibility , contrast (vision) , chest pain , intravenous contrast , anesthesia , cardiology , surgery , computed tomography , statistics , mathematics , artificial intelligence , computer science
The contrast agent SHU‐454 was intravenously injected in 103 patients during echocardiography: 37 mL/patient ± 7 ml/patient. The quality of the contrast effect was optimal in 13, good in 51, sufficient in 30, and poor in 9 patients; reproducibility was optimal in 38, good in 46, sufficient in 17, and poor in 2 patients. Taste sensation, arm discomfort, or atypical chest pain occurred in 5 patients, premature ventricular contractions in 3. An isolated anginal attack occurred in 1 patient with frequent episodes at rest. A slight reduction in hematologic indices was attributed to hemodilution. Thus, SHU‐454 produces a good and reproducible contrast effect with tolerable side effects.